Search Results
Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA
Search for other papers by C Spitzweg in
Google Scholar
PubMed
Search for other papers by P J Nelson in
Google Scholar
PubMed
Search for other papers by E Wagner in
Google Scholar
PubMed
Search for other papers by P Bartenstein in
Google Scholar
PubMed
Search for other papers by W A Weber in
Google Scholar
PubMed
Search for other papers by M Schwaiger in
Google Scholar
PubMed
Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA
Search for other papers by J C Morris in
Google Scholar
PubMed
Introduction Based on its well-characterized role in radioiodine imaging and therapy in differentiated thyroid cancer, the sodium iodide symporter (NIS) represents one of the oldest targets for molecular imaging and targeted radionuclide
Thyroid Cancer Research Laboratory, Thyroid Oncology Program, Medical Service, Veterans Affairs Medical Center, Lexington, Kentucky 40511, USA
Search for other papers by Wei Li in
Google Scholar
PubMed
Thyroid Cancer Research Laboratory, Thyroid Oncology Program, Medical Service, Veterans Affairs Medical Center, Lexington, Kentucky 40511, USA
Search for other papers by Kenneth B Ain in
Google Scholar
PubMed
Medicine and Molecular Imaging 29 842 – 854 . Pohlenz J Refetoff S 1999 Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidism . Biochimie 81 469 – 476 . Pohlenz J Duprez
Department of Endocrinology and Nutrition, Hospital Universitario de Móstoles, Madrid, Spain
Molecular Endocrinology Group, Faculty of Medicine, Universidad Francisco de Vitoria, Madrid, Spain
Centro de Investigaciones Biomédicas en Red, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
Search for other papers by Garcilaso Riesco-Eizaguirre in
Google Scholar
PubMed
Centro de Investigaciones Biomédicas en Red, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
Search for other papers by Pilar Santisteban in
Google Scholar
PubMed
Endocrine Tumors Unit, Unidad Funcional de Investigación en Enfermedades Crónicas (UFIEC), Instituto de Salud Carlos III, Madrid, Spain
Search for other papers by Antonio De la Vieja in
Google Scholar
PubMed
characterized ( Dai et al. 1996 ). Nancy Carrasco’s group demonstrated that a sodium/iodide symporter (NIS) actively transports two ions of sodium along with one of iodide into the cells using the favorable gradient of Na + . NIS is localized in the
Search for other papers by T Kogai in
Google Scholar
PubMed
Search for other papers by K Taki in
Google Scholar
PubMed
Search for other papers by G A Brent in
Google Scholar
PubMed
gland. Figure 2 Comparison of the human and rat sodium/iodide symporter (NIS) gene. (A) Three homologous regions (more than 60% homology) in the 5′-flanking region are shown. (B) Comparison of the NIS upstream enhancer (NUE) sequences of human and
Search for other papers by Christina Schug in
Google Scholar
PubMed
Search for other papers by Sarah Urnauer in
Google Scholar
PubMed
Search for other papers by Carsten Jaeckel in
Google Scholar
PubMed
Search for other papers by Kathrin A Schmohl in
Google Scholar
PubMed
Search for other papers by Mariella Tutter in
Google Scholar
PubMed
Search for other papers by Katja Steiger in
Google Scholar
PubMed
Search for other papers by Nathalie Schwenk in
Google Scholar
PubMed
Search for other papers by Markus Schwaiger in
Google Scholar
PubMed
Search for other papers by Ernst Wagner in
Google Scholar
PubMed
Search for other papers by Peter J Nelson in
Google Scholar
PubMed
Search for other papers by Christine Spitzweg in
Google Scholar
PubMed
MSCs as a tool to deliver therapeutic genes, such as the sodium iodide symporter ( NIS ), deep into tumor microenvironments ( Hagenhoff et al. 2016 , Melzer et al. 2016 ). NIS is an intrinsic transmembrane glycoprotein with 13 putative
Division of Endocrinology, Department of Endocrinology and Metabolism, Diabetes, and Metabolism, Laboratory for Cellular and Molecular Thyroid Research, Johns Hopkins University School of Medicine, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287, USA
Search for other papers by Zongjing Zhang in
Google Scholar
PubMed
Search for other papers by Dingxie Liu in
Google Scholar
PubMed
Search for other papers by Avaniyapuram Kannan Murugan in
Google Scholar
PubMed
Search for other papers by Zhimin Liu in
Google Scholar
PubMed
Search for other papers by Mingzhao Xing in
Google Scholar
PubMed
with decreased or lost expression of thyroid iodide-handling genes in PTC, particularly sodium iodide symporter (NIS; Xing 2007 a , Kim et al . 2012 , Xing et al . 2013 a ), which is normally localized in the basal membrane of thyroid cells and
CiberOnc, Instituto de Salud Carlos III, Madrid, Spain
Search for other papers by Antonio De la Vieja in
Google Scholar
PubMed
Department of Physiopathology of Endocrine a Nervous System, Instituto de Investigaciones Biomédicas ‘Alberto Sols’, Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid (CSIC-UAM), Madrid, Spain
Search for other papers by Pilar Santisteban in
Google Scholar
PubMed
undoubtedly the sodium/iodide symporter (NIS protein and SLC5A5 gene), an integral basolateral (BL) plasma membrane glycoprotein that actively accumulates I − driven by the electrochemical gradient of Na+ across the membrane ( Levy et al . 1998 ). NIS can
Search for other papers by Guo-Qiang Zhang in
Google Scholar
PubMed
Search for other papers by Chuang Xi in
Google Scholar
PubMed
Search for other papers by Chen-Tian Shen in
Google Scholar
PubMed
Search for other papers by Hong-Jun Song in
Google Scholar
PubMed
Search for other papers by Quan-Yong Luo in
Google Scholar
PubMed
Search for other papers by Zhong-Ling Qiu in
Google Scholar
PubMed
cases progress to radioiodine-refractory disease–PTC (RR–PTC), which has a 10-year survival rate of less than 10% ( Durante et al. 2006 ). Sodium/iodide symporter (NIS; solute carrier family 1 member 5) is constitutively expressed on the basolateral
Search for other papers by Camille Buffet in
Google Scholar
PubMed
Search for other papers by Johanna Wassermann in
Google Scholar
PubMed
Search for other papers by Fabio Hecht in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Université Paris-Saclay et Gustave Roussy, Villejuif, France
Search for other papers by Corinne Dupuy in
Google Scholar
PubMed
Université de Paris, Paris, France
Department of Endocrinology, APHP, Cochin Hospital, Paris, France
Search for other papers by Lionel Groussin in
Google Scholar
PubMed
PARCC, INSERM, Equipe Labellisée par la Ligue contre le Cancer, Paris, France
Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed
membrane of normal and tumoral thyroid epithelial cells of a symporter, the sodium iodide symporter (NIS), that transports two sodium ions and one iodide ion into the cytosol. Iodide is then handled by an iodine-metabolizing machinery that concentrates
Search for other papers by Cristina Romei in
Google Scholar
PubMed
Search for other papers by Raffaele Ciampi in
Google Scholar
PubMed
Search for other papers by Pinuccia Faviana in
Google Scholar
PubMed
Search for other papers by Laura Agate in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Search for other papers by Fulvio Basolo in
Google Scholar
PubMed
Search for other papers by Paolo Miccoli in
Google Scholar
PubMed
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Departments of, Endocrinology and Metabolism, Oncology, Surgery, Department of Internal Medicine, AMBISEN Center, University of Pisa, 56100 Pisa, Italy
Search for other papers by Aldo Pinchera in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
receptor (TSH-R), sodium iodide symporter gene (NIS), thyroid transcription factor-1 (TTF-1), and PAX-8; Elisei et al . 1994 , Arturi et al . 1998 ). The dedifferentiation process is responsible for a worse prognosis in these PTCs as they are usually